GHCL Q1 FY27 Results (NSE: GHCL)
Signal: Margin expansion
The read
GHCL's Q1FY27 headline PAT beat (+32% YoY) is entirely driven by an exceptional gain (20.8% of PBT) and other income — operating profit grew only 4% on a -2.7% revenue decline. The EBITDA margin expanded 160bps YoY to 30%, marking the fourth straight quarter of YoY expansion, but this is a continuation of a recovery from trough levels (Q3FY25 OPM 21%) rather than a new uptrend. Revenue remains under pressure (-2.7% YoY) as commodity chemical pricing stays soft. Without the exceptional item, PAT would have been ~₹138 Cr, flat to slightly down YoY. Valuation remains cheap at P/E 8.8x vs industry 20.6x, but the growth trajectory lacks organic momentum.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹774.26 Cr | -2.7% | -74.7% |
| EBIT | ₹205.46 Cr | 4.0% | |
| Net profit | ₹191.18 Cr | 32.0% | |
| EPS | ₹21.04 | 38.7% | |
| EBIT margin | 30% |
P&L walk
Standalone-only filing; no consolidated statement printed.
Key positives
- EBITDA margin improved 160bps YoY to 30%, fourth consecutive quarter of YoY margin expansion.
- EPS up 38.7% YoY to ₹21.04; PAT up 32% YoY to ₹191.18 Cr.
- Net debt low at ₹167.68 Cr (0.02 D/E ratio from fundamentals), ample financial flexibility.
- Valuation at P/E 8.8x and EV/EBITDA 5.4x, deep discount to industry averages.
Key concerns
- Revenue declined 2.7% YoY, indicating weak demand/pricing in commodity chemicals.
- PAT growth is artificially high: exceptional items contributed 20.8% of PBT; excluding them, PAT would have been flat.
- EBITDA margin contracted 1400bps QoQ sequentially (though Q4 is annual cumulative, making QoQ comparison less meaningful).
- 3-year revenue CAGR of -3.75% and profit CAGR of -24% reflect prolonged structural headwinds in soda ash/commodity chemical cycle.
Earnings quality: includes an exceptional item
Research and educational content only. Not investment advice.